Roivant Sciences Ltd. (ROIV)

NasdaqGS • Currently up 0.52 (+1.51%) in today's trading session

1 member of Congress has disclosed 4 trades in Roivant Sciences Ltd. (ROIV) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 31 October 2025. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Roivant Sciences Ltd. is currently trading at $34.93, positioned at 88% of its 52-week range ($12.54 – $37.97).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$34.93
24h Change
+0.52 (+1.51%)
52 Week Range
$12.54–$37.97
View on NASDAQ

Roivant Sciences Ltd. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ROIV

Select to highlight on chart
4 transactions
Compliance: 75%
Lisa McClain31 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A
Lisa McClain30 Oct 202521 Nov 2025PurchaseStock$1,001 - $15,000+86.19%
Lisa McClain30 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A
Lisa McClain17 Jun 202513 Aug 2025PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$25.23B

Volume

5.24M

Beta

1.12

P/E Ratio

-33.23

Fundamentals

EPS

$-1.05

Div. Yield

-

Open

$34.02

Day Range

$33.88 – $35.14

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
GB
CEO
Matthew Gline
IPO Date
2020-12-08
Website
roivant.com

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid...

Earnings

Next Report

Q3 2026

9 Nov

EPS Est.

$-0.41

Rev. Est.

$3.9M

Days Until

63

Recent Quarters

Q2 20266 Aug
EPS$-0.33
Miss 10.1%
Q1 202620 May
EPS$-0.28
Beat 3.5%
Q4 20256 Feb
EPS$-0.24
Beat 19.9%
Q3 202510 Nov
EPS$-0.20
Beat 36.9%
Q2 202511 Aug
EPS$-0.25
Miss 0.8%
Q1 202529 May
EPS$-0.29
Miss 10.1%
Q4 202410 Feb
EPS$-0.23
Beat 9.0%
Q3 202412 Nov
EPS$-0.29
Miss 17.4%
Q2 20248 Aug
EPS$0.12
Beat 149.3%
Q1 202430 May
EPS$-0.23
Beat 13.0%
Q4 202313 Feb
EPS$-0.21
Beat 32.0%
Q3 202313 Nov
EPS$-0.26
Beat 7.1%
Q2 202314 Aug
EPS$-0.38
Miss 26.7%
Q1 202328 Jun
EPS$-0.20
Beat 51.2%
Q4 202213 Feb
EPS$-0.49
Miss 36.1%
Q3 202214 Nov
EPS$-0.42
Miss 2.4%
Q2 202215 Aug
EPS$-0.48
Miss 60.0%
Q1 202228 Jun
EPS$-0.39
Miss 56.0%
Q4 202114 Feb
EPS$-0.41
Miss 78.3%
Q3 202115 Nov
EPS$-0.26
Beat 42.2%
Q2 202121 Sept
EPS-
Q2 202110 Aug
EPS-

3 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

PLTR

Palantir Technologies Inc.

20
$174.33-8.20 (-4.49%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

TSM

Taiwan Semiconductor Manufacturing Company Limited

20
$428.91+11.90 (+2.85%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$230.36+1.91 (+0.84%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about ROIV

Which members of Congress have traded ROIV?
1 member of Congress has disclosed 4 trade in Roivant Sciences Ltd. (ROIV) under the STOCK Act: Lisa McClain.
When was ROIV most recently disclosed by Congress?
The most recent ROIV disclosure was a sale by Lisa McClain on 31 October 2025.
What is the total disclosed congressional trading volume for ROIV?
Members of Congress have disclosed approximately $16K in ROIV purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ROIV?
This ROIV page updates as soon as new STOCK Act disclosures are filed for Roivant Sciences Ltd.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.